Cargando…

A clinical randomized controlled trial: moxibustion at Laogong interval with Panax notoginseng promoted the maturation of arteriovenous fistulae

BACKGROUND: We aim to study the clinical effect of moxibustion at Laogong interval with Panax notoginseng on the short-term maturation and long-term patency of arteriovenous fistula. METHODS: Seventy-four pre-dialysis uremic patients who received distal forearm radial-cephalic fistula creations were...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yurou, Xu, Lin, Huang, Di, Chen, Dongping, Wu, Feng, Wang, Luobing, Zhou, Jie, Lan, Tianying, Qin, Xuehua, Ye, Chaoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019999/
https://www.ncbi.nlm.nih.gov/pubmed/35443733
http://dx.doi.org/10.1186/s13020-022-00604-9
_version_ 1784689428707409920
author Chen, Yurou
Xu, Lin
Huang, Di
Chen, Dongping
Wu, Feng
Wang, Luobing
Zhou, Jie
Lan, Tianying
Qin, Xuehua
Ye, Chaoyang
author_facet Chen, Yurou
Xu, Lin
Huang, Di
Chen, Dongping
Wu, Feng
Wang, Luobing
Zhou, Jie
Lan, Tianying
Qin, Xuehua
Ye, Chaoyang
author_sort Chen, Yurou
collection PubMed
description BACKGROUND: We aim to study the clinical effect of moxibustion at Laogong interval with Panax notoginseng on the short-term maturation and long-term patency of arteriovenous fistula. METHODS: Seventy-four pre-dialysis uremic patients who received distal forearm radial-cephalic fistula creations were enrolled in this study and randomly assigned to the control group and experimental group. After arteriovenous fistula creations, the control group underwent handgrip exercise, and the experimental group received moxibustion at Laogong acupoint interval with Panax notoginseng. Both groups received a 12-week treatment and were followed up for 24 weeks in all at the following time points: before creations and 2, 4, 8, 12, 24 weeks after creations. The diameter of anastomosis, the diameter and outflow of draining-veins 5 cm above anastomosis, the diameter and outflow of brachial arteries evaluated the maturation and patency of arteriovenous fistula. Enzyme linked immunosorbent assay determined serum levels of endothelin and nitric oxide. RESULTS: The maturity rate in the experimental group was significantly higher than that in the control group at 4 weeks after arteriovenous fistula creations (P = 0.048). The diameter of anastomosis, the diameter of draining veins, and the blood flow of draining veins increased in both groups during the whole 24 weeks. The diameter and blood flow of brachial arteries ascended in both groups during the previous 12 weeks. Compared with the control group, moxibustion at Laogong interval with Panax notoginseng significantly improved the value of the diameter of draining-veins (P = 0.016), the blood flow of draining-veins (P = 0.015), the diameter of brachial arteries (P < 0.001), and the blood flow of brachial arteries (P = 0. 012) at 2 weeks, and enhanced the blood flow of draining-veins (P = 0.029) and brachial arteries (P < 0.001) at 12 weeks. Serum levels of endothelin were significantly lower (P = 0.047), and serum levels of nitric oxide were markedly higher (P < 0.001) in the experimental group than that in the control group at 2 weeks after creations. CONCLUSIONS: Moxibustion at Laogong interval with Panax notoginseng was non-invasive and promoted the maturation of arteriovenous fistula at 4 weeks after creations. However, its long-term beneficial effect on patency at 24 weeks after creations was not significant. Trial registration Chinese Clinical Trial Registry, No. ChiCTR1900024042. Registered, http://www.chictr.org.cn/index.aspx
format Online
Article
Text
id pubmed-9019999
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90199992022-04-21 A clinical randomized controlled trial: moxibustion at Laogong interval with Panax notoginseng promoted the maturation of arteriovenous fistulae Chen, Yurou Xu, Lin Huang, Di Chen, Dongping Wu, Feng Wang, Luobing Zhou, Jie Lan, Tianying Qin, Xuehua Ye, Chaoyang Chin Med Research BACKGROUND: We aim to study the clinical effect of moxibustion at Laogong interval with Panax notoginseng on the short-term maturation and long-term patency of arteriovenous fistula. METHODS: Seventy-four pre-dialysis uremic patients who received distal forearm radial-cephalic fistula creations were enrolled in this study and randomly assigned to the control group and experimental group. After arteriovenous fistula creations, the control group underwent handgrip exercise, and the experimental group received moxibustion at Laogong acupoint interval with Panax notoginseng. Both groups received a 12-week treatment and were followed up for 24 weeks in all at the following time points: before creations and 2, 4, 8, 12, 24 weeks after creations. The diameter of anastomosis, the diameter and outflow of draining-veins 5 cm above anastomosis, the diameter and outflow of brachial arteries evaluated the maturation and patency of arteriovenous fistula. Enzyme linked immunosorbent assay determined serum levels of endothelin and nitric oxide. RESULTS: The maturity rate in the experimental group was significantly higher than that in the control group at 4 weeks after arteriovenous fistula creations (P = 0.048). The diameter of anastomosis, the diameter of draining veins, and the blood flow of draining veins increased in both groups during the whole 24 weeks. The diameter and blood flow of brachial arteries ascended in both groups during the previous 12 weeks. Compared with the control group, moxibustion at Laogong interval with Panax notoginseng significantly improved the value of the diameter of draining-veins (P = 0.016), the blood flow of draining-veins (P = 0.015), the diameter of brachial arteries (P < 0.001), and the blood flow of brachial arteries (P = 0. 012) at 2 weeks, and enhanced the blood flow of draining-veins (P = 0.029) and brachial arteries (P < 0.001) at 12 weeks. Serum levels of endothelin were significantly lower (P = 0.047), and serum levels of nitric oxide were markedly higher (P < 0.001) in the experimental group than that in the control group at 2 weeks after creations. CONCLUSIONS: Moxibustion at Laogong interval with Panax notoginseng was non-invasive and promoted the maturation of arteriovenous fistula at 4 weeks after creations. However, its long-term beneficial effect on patency at 24 weeks after creations was not significant. Trial registration Chinese Clinical Trial Registry, No. ChiCTR1900024042. Registered, http://www.chictr.org.cn/index.aspx BioMed Central 2022-04-20 /pmc/articles/PMC9019999/ /pubmed/35443733 http://dx.doi.org/10.1186/s13020-022-00604-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chen, Yurou
Xu, Lin
Huang, Di
Chen, Dongping
Wu, Feng
Wang, Luobing
Zhou, Jie
Lan, Tianying
Qin, Xuehua
Ye, Chaoyang
A clinical randomized controlled trial: moxibustion at Laogong interval with Panax notoginseng promoted the maturation of arteriovenous fistulae
title A clinical randomized controlled trial: moxibustion at Laogong interval with Panax notoginseng promoted the maturation of arteriovenous fistulae
title_full A clinical randomized controlled trial: moxibustion at Laogong interval with Panax notoginseng promoted the maturation of arteriovenous fistulae
title_fullStr A clinical randomized controlled trial: moxibustion at Laogong interval with Panax notoginseng promoted the maturation of arteriovenous fistulae
title_full_unstemmed A clinical randomized controlled trial: moxibustion at Laogong interval with Panax notoginseng promoted the maturation of arteriovenous fistulae
title_short A clinical randomized controlled trial: moxibustion at Laogong interval with Panax notoginseng promoted the maturation of arteriovenous fistulae
title_sort clinical randomized controlled trial: moxibustion at laogong interval with panax notoginseng promoted the maturation of arteriovenous fistulae
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019999/
https://www.ncbi.nlm.nih.gov/pubmed/35443733
http://dx.doi.org/10.1186/s13020-022-00604-9
work_keys_str_mv AT chenyurou aclinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT xulin aclinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT huangdi aclinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT chendongping aclinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT wufeng aclinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT wangluobing aclinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT zhoujie aclinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT lantianying aclinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT qinxuehua aclinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT yechaoyang aclinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT chenyurou clinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT xulin clinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT huangdi clinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT chendongping clinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT wufeng clinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT wangluobing clinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT zhoujie clinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT lantianying clinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT qinxuehua clinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae
AT yechaoyang clinicalrandomizedcontrolledtrialmoxibustionatlaogongintervalwithpanaxnotoginsengpromotedthematurationofarteriovenousfistulae